Lauric acid can improve the sensitization of cetuximab in KRAS/BRAF-mutated CRC cells by inducing microRNA-378 expression, and it has no adverse effects on the cardiovascular system [40]. The gene discussed is BRAF; the disease is colorectal carcinoma.